Income Tax Expense (Benefit) in USD of Horizon Therapeutics Public Ltd Co from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Income Tax Expense (Benefit) history and change rate from Q2 2010 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Income Tax Expense (Benefit) for the quarter ending 30 Jun 2023 was $8.18M, a 115% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co Income Tax Expense (Benefit) for the twelve months ending 30 Jun 2023 was $5.86M.
  • Horizon Therapeutics Public Ltd Co annual Income Tax Expense (Benefit) for 2022 was $5.45M.
  • Horizon Therapeutics Public Ltd Co annual Income Tax Expense (Benefit) for 2021 was -$71.7M, a 705% decline from 2020.
  • Horizon Therapeutics Public Ltd Co annual Income Tax Expense (Benefit) for 2020 was $11.8M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Horizon Therapeutics Public Ltd Co Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $5.86M $8.18M +$4.37M +115% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $1.49M -$35.5M -$3.96M -12.6% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2023
Q4 2022 $5.45M $33.9M -$3.95M -10.4% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2023
Q3 2022 $9.41M -$758K +$18.5M +96.1% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 -$9.14M $3.81M +$46.3M 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$55.4M -$31.5M +$16.2M +34% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 -$71.7M $37.9M -$1.12M -2.87% 01 Oct 2021 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 -$70.5M -$19.3M +$71.8M +78.8% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 -$142M -$42.5M -$125M -151% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 -$16.9M -$47.8M -$28.7M -151% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $11.8M $39M +$595M 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023
Q3 2020 -$583M -$91.1M -$60.5M -198% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 -$523M $83M +$87.8M 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 -$610M -$19M -$17.1M -891% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 -$593M -$556M -$507M -1033% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022
Q3 2019 -$86.4M -$30.6M -$29.3M -2314% 01 Jul 2019 30 Sep 2019 10-Q 02 Nov 2020
Q2 2019 -$57.1M -$4.88M -$9.5M -205% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020
Q1 2019 -$47.6M -$1.92M -$2.87M -303% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 -$44.8M -$49.1M +$17.5M +26.3% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2020
Q3 2018 -$62.2M -$1.27M -$8.45M -118% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 -$53.8M $4.62M +$6.39M 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 -$60.2M $945K +$48.5M 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q4 2017 -$109M -$66.5M -$37.2M -127% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020
Q3 2017 -$71.4M $7.18M +$34.9M 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018
Q2 2017 -$106M -$1.77M +$989K +35.9% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018
Q1 2017 -$107M -$47.6M -$46.1M -3195% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 -$61.3M -$29.3M +$6.15M +17.3% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019
Q3 2016 -$67.4M -$27.7M -$49.7M -226% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017
Q2 2016 -$17.7M -$2.76M +$158M +98.3% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 -$176M -$1.44M -$3.36M -175% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017
Q4 2015 -$172M -$35.5M -$32.6M -1159% 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2018
Q3 2015 -$140M $22M +$25M 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016
Q2 2015 -$165M -$161M -$162M -18359% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016
Q1 2015 -$3.07M $1.91M +$3.02M 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q4 2014 -$6.08M -$2.82M -$2.66M -1729% 01 Oct 2014 31 Dec 2014 10-K 27 Feb 2017
Q3 2014 -$3.42M -$3.04M -$3.31M -1248% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015
Q2 2014 -$114K $880K +$1.23M 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015
Q1 2014 -$1.35M -$1.11M -$224K -25.4% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015
Q4 2013 -$1.12M -$154K +$182K +54.2% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016
Q3 2013 -$1.3M $265K +$4.78M 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014
Q2 2013 -$6.08M -$351K -$192K -121% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014
Q1 2013 -$5.89M -$881K -$717K -437% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014
Q4 2012 -$5.17M -$336K +$13.8M +97.6% 01 Oct 2012 31 Dec 2012 10-K/A 02 Mar 2015
Q3 2012 -$19M -$4.51M -$4.34M -2449% 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013
Q2 2012 -$14.6M -$159K +$27K +14.5% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013
Q1 2012 -$14.7M -$164K +$18K +9.89% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 -$14.7M -$14.1M 01 Oct 2011 31 Dec 2011 10-K 13 Mar 2014
Q3 2011 -$177K -$193K -1206% 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012
Q2 2011 -$186K -$199K -1531% 01 Apr 2011 30 Jun 2011 10-Q 10 Aug 2012
Q1 2011 -$182K 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012
Q3 2010 $16K 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 $13K 01 Apr 2010 30 Jun 2010 10-Q 02 Sep 2011

Horizon Therapeutics Public Ltd Co Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $5.45M +$77.1M 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023
2021 -$71.7M -$83.5M -705% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023
2020 $11.8M +$605M 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
2019 -$593M -$548M -1226% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 -$44.8M +$63.9M +58.8% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021
2017 -$109M -$47.4M -77.4% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 -$61.3M +$111M +64.4% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
2015 -$172M -$166M -2731% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018
2014 -$6.08M -$4.96M -443% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017
2013 -$1.12M +$4.05M +78.3% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 -$5.17M +$9.51M +64.8% 01 Jan 2012 31 Dec 2012 10-K/A 02 Mar 2015
2011 -$14.7M -$14M -2125% 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014
2010 -$660K 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.